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Objective: To assess the integration of decellularized heterologous collagen matrices into 
the urethra, when implanted with no cells or when seeded with autologous smooth mus-
cle cells.
Materials and Methods: Eighteen New Zealand rabbits were randomly assigned to two 
groups: Group I (n = 9) - animals undergoing urethral segment resection with interposi-
tion of a patch of heterologous collagen matrix seeded with autologous smooth muscle 
cells; Group II (n = 9) - animals undergoing resection of a urethral segment with inter-
position of a decellularized heterologous collagen matrix patch. Two animals from each 
group were sacrificed on postoperative days seven, fourteen and twenty-eight; three 
animals from each group were sacrificed at the end of three postoperative months. At the 
end of the third month one animal from each group underwent urethroscopy for urethral 
integrity assessment and one animal from each group had its microcirculation image 
captured by a SDF device (Side-stream Dark Field - Microscan Analysis Software). One 
animal from each group in each euthanasia period underwent cystourethrography so as 
the urethra could be viewed at flow time. The matrices integration was assessed through 
histological examination using hematoxylin and eosin (H&E), Masson trichrome (MT), 
Picrosirius red and Von Willebrand staining. In a blind study with two pathologists all 
the slides were studied.
Results: The matrices whether seeded or not with autologous muscle cells were able to 
restore the architecture of the urethra, but were eliminated from the first week on, before 
incorporation. Microcirculation of the neourethra, at the end of the third month, showed 
the same characteristics as a normal urethra in both groups of animals.
Conclusion: Natural heterologous matrices implanted in the urethra as onlay graft were 
not incorporated into its walls but were able to fully restore the cell architecture of the 
organ, regardless of being seeded or not with autologous muscle cells.
INTRODUCTION
Urethral reconstruction is frequently used 
in the treatment of both congenital and acquired 
anomalies (1-6). When the urethra needs to be re-
paired or reconstructed, either partially or totally, 
different surgical approaches can be used such as 
anastomosis of the urethral stumps, flaps or grafts. 
Although such techniques are still largely em-
ployed, in several occasions adverse effects such 
as fistulas, stenosis, infections, stone formation, 
graft contracture or diverticula formation may 
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appear. In addition to morbidity at the donor site, 
there is tissue scarcity when such patients undergo 
a number of surgical interventions (1,2,4-12).
 Tissue engineering techniques are an al-
ternative for such difficulties. A decellularized 
matrix, either natural or synthetic, may serve as 
a pattern for implantation of individual cells pre-
viously obtained by harvesting a full fragment 
from the very organ. The different cell layers are 
separated by using different techniques, expanded 
“in vitro”, and then seeded in the matrix before 
reimplantation (5). The different researchers that 
use cell-seeded matrices describe the process of 
matrix incorporation into the new urethra, howe-
ver, not observing the manner in which this incor-
poration actually takes place in the early phases of 
tissue repair.
This paper aimed to study the evolution of 
decellularized heterologous matrices integration 
along time, whether or not seeded with autolo-
gous smooth muscle cells and implanted into the 
urethra.
MATERIALS AND METHODS
All experimental procedures were appro-
ved by the local Research Ethics Committee (CEP - 
0939/07) and conducted in strict conformity with 
local institutional guidelines and with internatio-
nal standards for manipulation and care of labo-
ratory animals.
 Eighteen New Zealand male rabbits, 6 to 8 
months old, weighing approximately 3 kg, from the 
Center for Development of Experimental Models for 
Medicine and Biology of the Federal University of 
São Paulo, were used. The animals were assigned to 
2 groups of nine animals each. The animals in both 
groups underwent resection of a 3.5 cm long by 0.5 
cm wide fragment from the ventral portion of the 
penile urethra. The animals in Group I underwent 
interposition of a patch of decellularized heterolo-
gous matrices, of same size as the urethral segment 
withdrawn, seeded with autologous muscle cells; 
the animals in Group II underwent interposition of 
decellularized heterologous matrix patches, of same 
size as the segment withdrawn, however with no 
cells seeded. The matrix was sutured to the urethra 
using 6-0 polypropylene in a continuous fashion.
 The collagen matrices were taken from por-
cine bladders submucosa obtained from animals un-
dergoing different surgical procedures. They were 
kept in sterile tubes containing 50 ml PBS (Phospha-
te-Buffered Saline - Sigma Chemical Co., Saint Louis, 
USA), to which 10.000 Ul/L penicillin and 50 mg/L 
streptomycin were added. They were continuously 
agitated for fourteen days in Triton X-100 1% de-
tergent (Sigma Chemical CO, Saint Louis, USA) and 
0.1% ammonia hydroxide, which solution was chan-
ged every two days. On day fourteen the bladders 
were kept for twenty-four hours in distilled water in 
continuous agitation. Then, they underwent ultravio-
let radiation for one hour and, after that, they were 
cut into 3 x 5 cm fragments under a laminar flow 
chamber. The fragments were then kept in tubes con-
taining sterile PBS and stored at -20º C Celsius until 
they were used. A fragment of the material obtained 
was put in a 10% tamponade formaldehyde solution 
and forwarded for anatomopathological assessment.
 For the surgical procedures the animals were 
anesthetized with intramuscular ketamine (50 mg/
kg) and xylazine (10 mg/kg). During the procedures a 
venous infusion of physiological solution was main-
tained. The animals in Group I underwent median 
laparotomy. The bladder was isolated and a 1 cm2 
segment was withdrawn from the anterior wall; the 
bladder was then sutured with 4-0 polyglactin and 
the abdominal wall was sutured with 3-0 polyglactin. 
The bladder fragment withdrawn was taken to the 
laminar flow chamber and cut into 2 mm2 fragments 
after full removal of the mucosa. The fragments were 
placed on culture plates by using the “explant” te-
chnique, covered with Dulbecco’s modified Eagle’s 
medium (DMEM) and 10% fetal bovine serum, and 
incubated at 37º C in a 5% carbon dioxide atmos-
phere. Around day fourteen, when the culture plates 
showed cell confluence of approximately 80%, they 
were subjected to trypsin enzymatic action. The so-
lution was centrifuged, the cells were counted in a 
Neubauer chamber and seeded in the collagen ma-
trix, where they remained for another seven days in 
the same culture solution before being implanted.
 The animals from both groups were sacrifi-
ced by anesthetic deepening; two animals on days 
seven, fourteen and twenty-eight and 3 animals in 
the third postoperative month. One animal in every 
sacrifice period had its bladder and urethra removed 
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in block for a cystourethrography. The penises of all 
animals were removed in block and fixed in 10% 
buffered formaldehyde for 24 hours. The pieces were 
placed in paraffin blocks, cut into 5 micrometer sec-
tions, stained with hematoxylin-eosin (H&E), Mas-
son trichrome (MT), Picrosirius red and assessed with 
polarized light and immunohistochemistry using 
anti-Von Willebrand factor antibody and analyzed 
in optical microscopy with 150x augmentation. We 
observed the epithelial integrity, the inflammatory 
process and the amount of collagen, and scores 0 to 
3 were created for every item assessed (Table-1).
 At the end of the third postoperative month 
one animal in every group underwent urethrosco-
py with an Olympus Winter & Ibe GMBH, Hamburg, 
Germany, 17Fr sheath, 12 degree optics cystoscope 
and was assessed for the new urethra microcircu-
lation through an SDF device, 1 mm2 images from 
three different sites were captured, a 2 mmhh deep 
surface was assessed in 320x image augmentation; 
the images were saved in 10 second videos (13).
RESULTS
The urethroscopies performed showed the 
urethra with normal caliber - the 17Fr cystoscope 
was passed with no technical difficulty and an ade-
quate urinary flow was obtained after bladder com-
pression.
 The microcirculation assessed by the SDF 
showed low flow through venules, scarce capillaries, 
absence of arterioles, and low vascular density; these 
results were similar to the ones observed in normal 
rabbits urethras (Figure-1).
 The cystourethrografies performed showed 
urethras with normal caliber and adequate urinary 
flow (Figure-2).
 Histological analyses performed on postope-
rative day seven showed a disrupted area with a de-
posit of fibrin-leukocitary material and stroma rich in 
leukocytes, with predominating polymorphonuclears 
and presence of eosinophils in the animals of both 
groups, suggestive of an acute exudative inflamma-
tory process and of a recent intervention. The ma-
trix was already being eliminated into the lumen of 
the organ, and an epithelial layer of cells was being 
formed right below (Figure-3). On day fourteen, in 
both groups, the matrix was found to be in the ure-
thral lumen, the epithelium not fully formed yet, and 
the stroma with mixed inflammatory infiltrate with 
lymphocytes predominating, suggestive of an early 
chronification. The process was being resolved from 
bottom to top with good formation of the muscle 
layer (Figure-4). On day twenty-eight full reepithe-
lization could already be observed in the animals in 
both groups with inflammatory process, with predo-
minating lymphocytes, limited to the submucosa (Fi-
gure-5 a). A squamous metaplasia in the animals in 
the group without cells was observed (Figure-5 b). On 
day ninety the animals in both groups had urethral 
architecture similar to that of a normal urethra, ho-
wever still with a less intense chronic inflammatory 
process, with predominating lymphocytes, showing 
the scarring not to be fully resolved on day ninety 
(Figure-6) The result of the assessment made by two 
pathologists in a blind study can be seen in Table-1.
 Picrosirius red staining showed in all periods 
and in both groups, predominance of early type III 
collagen, even on day ninety (Figure-7).
 Immunochemistry using anti-Von Wille-
brand antibody demonstrated intense neoangioge-
nisis in both groups, with no differences between 
them (Figure-8).
DISCUSSION
The need to partially or fully reconstruct the 
urethra is relatively usual given the high number of 
patients with congenital or acquired diseases, and 
trauma victims. Thus, a large number of techniques 
have been used in the attempt to restore the anatomy 
of the organ, aiming to achieve adequate micturition 
and, in the cases of male patients, to enable forward 
ejaculation with an adequate amount of spermato-
zoids (1-5,7). All techniques used to date have a high 
rate of complications and, when such patients under-
go several procedures, which is quite usual, the use of 
flaps or grafts is almost always necessary (5-7,14,15).
 The surgical interventions employing grafts 
for urethral reconstruction have already led to the 
use of segments from the saphenous vein, from the 
appendix, from partial skin grafts and even from tis-
sues containing urothelium, such as the ureter and 
bladder mucosa (14-23). Synthetic materials such 
as dacron®, silicone and teflon®, have also been 
used, but, more recently, the use of buccal muco-
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Figure 1 - A - Photomicrography of the urethra - group I (seeded matrix), SDF 320x. B - Photomicrography of the urethra - 
group II (non-seeded matrix). SDF 320x.
A B
Figure 2 - A - Cystourethrography - Rabbit Group I (seeded heterologous matrix). Yellow line delimiting penile urethra subjected 
to matrix interposition. B - Cystourethrography Rabbit Group II (non-seeded heterologous matrix). Yellow line delimitating 
penile urethra subjected to matrix interposition.
Figure 3 - A - Photomicrography of the urethra - Group I animal, postoperative day 7, Black arrow = Matrix. Green arrow = 
inflammatory process. Blue arrow = epithelium. H&E 25x. B - Photomicrography of the urethra - Group II animal, postoperative 
day 7, Black arrow = Matrix. Green arrow = inflammatory process. Blue arrow = epithelium H&E, 25x.
A
A
B
B
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Table 1 - Anatomopathologic findings.
Groups Inflammation intensity Predominant Cells Layers
7 days 
No cells
3 Lymphocytes
Eosinophils
Neutrophils
Submucosa
(ulceration)
3 Lymphocytes
Eosinophils
Neutrophils
Submucosa
Muscular
7 days 
With cells
3 Lymphocytes
Neutrophils
Mucosa
Submucosa
Muscular
3 Lymphocytes
Neutrophils
Submucosa
Muscular
14 days 
No cells
3 Lymphocytes
Eosinophils
Neutrophils
Submucosa
3 Lymphocytes
Neutrophils
Submucosa
Muscular
14 days 
With cells
2 Lymphocytes Submucosa
2 Lymphocytes Submucosa
28 days 
No cells
2 Lymphocytes Mucosa
Submucosa
3 Lymphocytes Mucosa
Submucosa
28 days
With cells
1 Lymphocytes Submucosa
3 Neutrophils
Lymphocytes
Mucosa
Submucosa
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3 months 
No cells
1 Lymphocytes
Eosinophils
Neutrophils
Submucosa
2 Lymphocytes Submucosa
2 Lymphocytes Submucosa
3 months
With cells
2 Neuthrophils
Lymphocytes
Mucosa
Submucosa
2 Neuthrophils
Lymphocytes
Submucosa
3 Neutrophils Submucosa
0 - No inflammatory process
1 - Mild amount of inflammatory cells
2 - Moderate amount of inflammatory cells (more than 25% of the sample)
3 - Extended or severe inflammatory process (more than 50% of the sample)
Neutrophils - Acute Inflammation
Lymphocytes - Chronic Inflammation
Eosinophils - Exsudation
continuation
Figure 4 - A - Photomicrography of the urethra - group I animal, postoperative day 14, Blue arrow = epithelium Masson’s tri-
chrome, 25x. B - Photomicrography of the urethra - Group II animal, postoperative day 14, Blue arrow = epithelium. Masson’s 
trichrome, 25x.
A B
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Figure 5 - A - Photomicrography of the urethra - Group I animal, postoperative day 28, H&E, 25x. B - Photomicrography of the 
urethra - Group II animal, postoperative day 28. Blue arrow = squamous metaplasia. Masson’s trichrome, 25x.
Figure 6 - A - Photomicrography of the urethra - Group I animal, postoperative day 90, Masson’s trichrome, 25x. B - Photo-
micrography of the urethra - Group II animal, postoperative day 90, Masson’s trichrome, 25x.
A
A
B
B
sa appears to have become the gold standard in 
the treatment of major reconstructions, presenting 
the smallest rate of stenosis and fistulas, in the 
medium and long term. The number of adverse 
events, however, does not allow one to say yet 
that this would be the ideal urethral substitute 
(12,23-26).
 The recent advance of molecular biology, 
the large scale production of cell nutrients, and 
the possibility of cultivating cells “in vitro” and 
then implanting them in synthetic or natural ex-
tracellular matrices, thus reconstructing an organ, 
have led to the introduction of Tissue Enginee-
ring techniques. Combined with the employment 
of new materials these techniques may become 
important in the reconstruction or replacement of 
lost or insufficient organs or tissues, and a viable 
option in cases of lack or partial absence of tissues 
(5,27-29).
 Tissue Engineering uses either natural or 
synthetic matrices that should favor cell adhesion, 
proliferation, differentiation, and growth, and 
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their slow degradation by lysosomal enzymes, in 
the case of synthetic matrices that gradually lead 
to their absorption, with minimal toxicity and in-
flammatory reaction (3,5,7,9,30,31). Tissue engi-
neering techniques may allow for the creation of a 
reservoir of biocompatible tissues that can be used 
in extensive urethral reconstructions when there 
is a lack of autologous tissues for flaps or grafts 
on account of various prior surgeries.
In this study we sought to assess integra-
tion of a collagen matrix into the urethral wall. 
The collagen matrix was obtained of a porcine 
bladder by employing tissue engineering tech-
niques. Considering that in the different recons-
truction techniques, urothelial growth frequently 
takes place starting from the lateral borders in 
the transition between the patient’s urethra and 
the graft, we decided to test the hypothesis that 
implantation of the autologous smooth muscle 
cells alone with no need to use the urothelial layer 
could reconstruct the entire architecture of the 
organ. It was found, through endoscopy and ra-
diographic exams, that the macroscopic aspect of 
the urethral caliber of the animals in both groups 
Figure 7 - A - Photomicrography of the urethra - Group I animal, postoperative day 90, Picrosirius Red staining, 25x. Green 
area collagen (type III). B - Photomicrography of the urethra - Group II animal, postoperative day 90, Picrosirius Red staining, 
25x.  Blue area collagen (type III)
Figure 8 - A - Photomicrography of the urethra - Group I animal, postoperative day 90, immunohistochemistry with anti-Von 
Willebrand factor antibodies, 25x. B - Photomicrography of the urethra - Group II animal, postoperative day 90, immunohis-
tochemistry with anti-Von Willebrand factor antibodies, 25x.
A
A
B
B
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studied resembled that of a non-operated urethra, 
fact that had previously been observed by Chen et 
al., Atala et al. and El-Kassaby et al. using similar 
techniques (1,2,5,7,8).
 By using the SDF it was possible to assess 
the microcirculation that was established on the 
new urethra around postoperative day ninety; it 
also showed the vascular network to resemble that 
of a normal urethra, regardless of the matrix having 
or not been seeded with muscle cells.
 In order to verify the process of incor-
poration of the matrices into the urethral bed, 
histological assessment with hematoxylin-eosin, 
Masson’s trichrome, Picrosirius red and Von Wil-
lebrand staining were used. On day seven after 
implantation the animals in both groups had the 
same behavior in regard to epithelial integrity, to 
the inflammatory process and to the amount and 
type of collagen. The implanted matrix, instead 
of being incorporated and forming a portion of 
the urethral wall, was being eliminated into the 
organ’s lumen while, at the same time, the ana-
tomy of the urethra was being restored. On pos-
toperative days twenty-eight and ninety both 
groups showed epithelial integrity; the only diffe-
rence found was that on day twenty-eight most of 
the animals in which the cells were not seeded had 
squamous metaplasia, which means the existence 
of an intense inflammatory process that turns the 
original epithelium into a barrier that is more re-
sistant to aggressions.
 Decellularized collagen matrices of diffe-
rent origins are being used in urethral reconstruc-
tions. Chen et al observed cell infiltration and neo-
angiogenesis after two weeks, with disorganized 
migration of muscle fibers after two months (2). 
De Filippo et al comparing decellularized matri-
ces seeded or not with epithelial and muscle cells 
observed scarce vascular organization in the non-
-seeded matrices, contrasting with the good orga-
nization of the ones seeded (4). Our study was the 
first to make an early assessment of the heterolo-
gous matrices integration process. We demonstra-
ted that the matrix was actually eliminated into 
the lumen instead of being reincorporated, and the 
reason for such may be a possible greater matrix 
permeability to the urine, which can be explained, 
perhaps, by an exaggerated inflammatory process. 
Regardless of being incorporated, however, the 
entire layer was reconstructed, which may have 
occurred in other studies, considering that, appa-
rently, what really matters seems to be the presen-
ce of the matrix at the beginning of scarring.
 It can be said that the heterologous colla-
gen matrix, although not having been integrated 
into the native tissue, was capable of stimulating 
urethral remodeling when the dorsal bed of the 
original urethra was maintained. In those cases 
muscle cells seeding was not necessary for the 
urethral remodeling to be completed, and auto-
logous smooth muscle cells seeding, although ha-
ving lessened the inflammatory process, was not 
found to be indispensable for regeneration of both 
the original muscle and the epithelial layer.
CONCLUSIONS
Natural heterologous matrices implanted 
in the urethra as onlay graft were not incorpo-
rated into the urethral walls but were capable of 
restoring its entire cell architecture whether or not 
seeded with autologous muscle cells.
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